Glimepiride in type 2 diabetes mellitus: effect on the fatty acids level

dc.contributor.author	Pasiieshvili, Tamara
dc.contributor.author	Zhelezniaykova, Natalia
dc.date.accessioned	2018-05-02T19:36:20Z
dc.date.available	2018-05-02T19:36:20Z
dc.date.issued	2018
dc.description.abstract	The appearance of sulfonylurea drugs in the list of sugar-reducing medicines is associated with the accidental opening of their hypoglycemic effect in the prescription of antibacterial sul- fonamide terapy to the patients with infectious diseases. For today, three generations of these drugs are distinguished, among which the most used is glimepiride.	ru_RU
dc.identifier.citation	Pasiieshvili T. M. Glimepiride in type 2 diabetes mellitus: effect on the fatty acids level / T. M. Pasiieshvili, N. Zhelezniaykova // Актуальные проблемы современной медицины и фармации 2018 : сборник тезисов докладов LCXXII международной научно-практической конференции студентов и молодых ученых, Минск, 18–20 апреля 2018 г. / Белорусский государственный медицинский университет. – Минск, 2018. – С. 241.	ru_RU
dc.identifier.uri	https://repo.knmu.edu.ua/handle/123456789/19488
dc.language.iso	en	ru_RU
dc.subject	fatty acids level	ru_RU
dc.subject	glimepiride	ru_RU
dc.subject	type 2 diabetes	ru_RU
dc.title	Glimepiride in type 2 diabetes mellitus: effect on the fatty acids level	ru_RU
dc.type	Thesis	ru_RU

Files

Now showing 1 - 2 of 2

Now showing 1 - 1 of 1